Oncotarget

Corrections:

Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells

PDF  |  How to cite

Oncotarget. 2018; 9:35599-35599. https://doi.org/10.18632/oncotarget.26304

Metrics: PDF 545 views  |   ?  

Vojtech Novohradsky1, Juraj Zajac1, Oldrich Vrana1, Jana Kasparkova1 and Viktor Brabec1

1 Institute of Biophysics, Czech Academy of Sciences, Kralovopolska 135, CZ-61265 Brno, Czech Republic

Published: October 30, 2018

This article has been corrected: The correct Grant information is given below:

ACKNOWLEDGMENTS

This work was supported by the Czech Science Foundation, Grant No. 18-09502S. The authors thank to Dr. Klára Čépe, Dr. Václav Ranc and Zuzana Chaloupková from the Regional Centre of Advanced Technologies and Materials (Olomouc, Czech Republic) for the TEM, DLS and ξ-potential analysis.

Original article: Oncotarget. 2017; 8:13030-13038. DOI: https://doi.org/10.18632/oncotarget.25466.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26304